US Stock MarketDetailed Quotes

SPRY ARS Pharmaceuticals

Watchlist

8.350
+0.260+3.21%

Close Apr 26 16:00 ET

809.07MMarket Cap-14649P/E (TTM)

ARS Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-47.88%-59.27M

15.09%-17.41M

-124.62%-12.76M

-139.02%-16.67M

-79.48%-12.43M

-128.22%-40.08M

-20.5M

-5.68M

-6.97M

-6.93M

Net income from continuing operations

-56.75%-54.37M

50.32%-7.17M

-125.82%-14.87M

-170.56%-17.37M

-106.36%-14.96M

-71.33%-34.68M

---14.43M

---6.58M

---6.42M

---7.25M

Operating gains losses

----

3,600.00%140K

--143K

--0

---2K

---1K

Depreciation and amortization

-2,233.23%-6.81M

-2,396.32%-6.87M

200.00%21K

154.05%20K

-60.00%20K

49.77%319K

--299K

--7K

---37K

--50K

Other non cash items

----

--1.06M

--931K

--40K

----

Change In working capital

42.52%-7.33M

11.75%-10.77M

162.18%1.03M

135.04%335K

17,158.33%2.07M

-3,482.58%-12.75M

---12.2M

--394K

---956K

--12K

-Change in prepaid assets

-20.99%-1.44M

-60.74%-1.92M

-163.77%-88K

155.36%124K

383.70%445K

-201.11%-1.19M

---1.19M

--138K

---224K

--92K

-Change in payables and accrued expense

73.00%-2.78M

22.25%-8.88M

30.85%1.12M

183.90%224K

771.06%4.76M

-1,155.95%-10.29M

---11.42M

--859K

---267K

--546K

-Change in other working capital

-143.10%-3.12M

-67.47%27K

98.91%-3K

97.20%-13K

-400.00%-3.13M

48.74%-1.28M

--83K

---275K

---465K

---626K

Cash from discontinued investing activities

Operating cash flow

-47.88%-59.27M

15.09%-17.41M

-124.62%-12.76M

-139.02%-16.67M

-79.48%-12.43M

-128.22%-40.08M

---20.5M

---5.68M

---6.97M

---6.93M

Investing cash flow

Cash flow from continuing investing activities

-43,709.05%-87.18M

20,765.87%26.04M

-155,376.67%-46.64M

204,509.09%44.97M

-531,071.43%-111.55M

-261.82%-199K

-126K

-30K

-22K

-21K

Net PPE purchase and sale

12.06%-175K

172.22%91K

-43.33%-43K

-36.36%-30K

-819.05%-193K

-261.82%-199K

---126K

---30K

---22K

---21K

Net investment purchase and sale

---87.01M

--25.95M

---46.6M

--45M

---111.35M

--0

Cash from discontinued investing activities

Investing cash flow

-43,709.05%-87.18M

20,765.87%26.04M

-155,376.67%-46.64M

204,509.09%44.97M

-531,071.43%-111.55M

-261.82%-199K

---126K

---30K

---22K

---21K

Financing cash flow

Cash flow from continuing financing activities

-96.38%6.9M

-99.07%1.81M

159.19%921K

558.11%2.85M

245.26%1.32M

258.80%190.73M

193.82M

-1.56M

-623K

-908K

Net issuance payments of debt

--0

-377.77%-8.68M

---5.95M

---909K

---910K

---908K

Proceeds from stock option exercised by employees

1,110.35%6.9M

537.81%1.81M

--921K

894.43%2.85M

--1.32M

237.28%570K

--283K

--0

--287K

--0

Net other financing activities

----

--198.84M

--199.49M

----

Cash from discontinued financing activities

Financing cash flow

-96.38%6.9M

-99.07%1.81M

159.19%921K

558.11%2.85M

245.26%1.32M

258.80%190.73M

--193.82M

---1.56M

---623K

---908K

Net cash flow

Beginning cash position

250.50%210.52M

62.19%60.53M

166.91%119.02M

68.29%87.86M

250.50%210.52M

144.95%60.06M

--37.32M

--44.59M

--52.21M

--60.06M

Current changes in cash

-192.75%-139.55M

-93.97%10.44M

-704.69%-58.49M

508.91%31.16M

-1,461.70%-122.66M

323.32%150.46M

--173.2M

---7.27M

---7.62M

---7.85M

End cash Position

-66.29%70.97M

62.19%60.53M

166.91%119.02M

68.29%87.86M

250.50%210.52M

--210.52M

--37.32M

--44.59M

--52.21M

Free cash flow

-47.58%-59.44M

16.05%-17.31M

-124.19%-12.81M

-138.69%-16.7M

-81.72%-12.62M

-128.64%-40.28M

---20.62M

---5.71M

---7M

---6.95M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-47.88%-59.27M	15.09%-17.41M	-124.62%-12.76M	-139.02%-16.67M	-79.48%-12.43M	-128.22%-40.08M	-20.5M	-5.68M	-6.97M	-6.93M
Net income from continuing operations	-56.75%-54.37M	50.32%-7.17M	-125.82%-14.87M	-170.56%-17.37M	-106.36%-14.96M	-71.33%-34.68M	---14.43M	---6.58M	---6.42M	---7.25M
Operating gains losses	----	----	----	----	----	3,600.00%140K	--143K	--0	---2K	---1K
Depreciation and amortization	-2,233.23%-6.81M	-2,396.32%-6.87M	200.00%21K	154.05%20K	-60.00%20K	49.77%319K	--299K	--7K	---37K	--50K
Other non cash items	----	----	----	----	----	--1.06M	--931K	--40K	----	----
Change In working capital	42.52%-7.33M	11.75%-10.77M	162.18%1.03M	135.04%335K	17,158.33%2.07M	-3,482.58%-12.75M	---12.2M	--394K	---956K	--12K
-Change in prepaid assets	-20.99%-1.44M	-60.74%-1.92M	-163.77%-88K	155.36%124K	383.70%445K	-201.11%-1.19M	---1.19M	--138K	---224K	--92K
-Change in payables and accrued expense	73.00%-2.78M	22.25%-8.88M	30.85%1.12M	183.90%224K	771.06%4.76M	-1,155.95%-10.29M	---11.42M	--859K	---267K	--546K
-Change in other working capital	-143.10%-3.12M	-67.47%27K	98.91%-3K	97.20%-13K	-400.00%-3.13M	48.74%-1.28M	--83K	---275K	---465K	---626K
Cash from discontinued investing activities
Operating cash flow	-47.88%-59.27M	15.09%-17.41M	-124.62%-12.76M	-139.02%-16.67M	-79.48%-12.43M	-128.22%-40.08M	---20.5M	---5.68M	---6.97M	---6.93M
Investing cash flow
Cash flow from continuing investing activities	-43,709.05%-87.18M	20,765.87%26.04M	-155,376.67%-46.64M	204,509.09%44.97M	-531,071.43%-111.55M	-261.82%-199K	-126K	-30K	-22K	-21K
Net PPE purchase and sale	12.06%-175K	172.22%91K	-43.33%-43K	-36.36%-30K	-819.05%-193K	-261.82%-199K	---126K	---30K	---22K	---21K
Net investment purchase and sale	---87.01M	--25.95M	---46.6M	--45M	---111.35M	--0	--0	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	-43,709.05%-87.18M	20,765.87%26.04M	-155,376.67%-46.64M	204,509.09%44.97M	-531,071.43%-111.55M	-261.82%-199K	---126K	---30K	---22K	---21K
Financing cash flow
Cash flow from continuing financing activities	-96.38%6.9M	-99.07%1.81M	159.19%921K	558.11%2.85M	245.26%1.32M	258.80%190.73M	193.82M	-1.56M	-623K	-908K
Net issuance payments of debt	--0	--0	--0	--0	--0	-377.77%-8.68M	---5.95M	---909K	---910K	---908K
Proceeds from stock option exercised by employees	1,110.35%6.9M	537.81%1.81M	--921K	894.43%2.85M	--1.32M	237.28%570K	--283K	--0	--287K	--0
Net other financing activities	----	----	----	----	----	--198.84M	--199.49M	----	----	----
Cash from discontinued financing activities
Financing cash flow	-96.38%6.9M	-99.07%1.81M	159.19%921K	558.11%2.85M	245.26%1.32M	258.80%190.73M	--193.82M	---1.56M	---623K	---908K
Net cash flow
Beginning cash position	250.50%210.52M	62.19%60.53M	166.91%119.02M	68.29%87.86M	250.50%210.52M	144.95%60.06M	--37.32M	--44.59M	--52.21M	--60.06M
Current changes in cash	-192.75%-139.55M	-93.97%10.44M	-704.69%-58.49M	508.91%31.16M	-1,461.70%-122.66M	323.32%150.46M	--173.2M	---7.27M	---7.62M	---7.85M
End cash Position	-66.29%70.97M	-66.29%70.97M	62.19%60.53M	166.91%119.02M	68.29%87.86M	250.50%210.52M	--210.52M	--37.32M	--44.59M	--52.21M
Free cash flow	-47.58%-59.44M	16.05%-17.31M	-124.19%-12.81M	-138.69%-16.7M	-81.72%-12.62M	-128.64%-40.28M	---20.62M	---5.71M	---7M	---6.95M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall